TB Alternative Assets’s Ginkgo Bioworks DNA Stock Holding History

TB Alternative Assets’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-18,625	Closed	-$864K	–	41
2024 Q1	$864K	Hold	18,625	–	–	0.22%	35
2023 Q4	$1.26M	Buy	18,625 +10,592	+132%	+$649K	0.34%	36
2023 Q3	$582K	Hold	8,033	–	–	0.16%	38
2023 Q2	$598K	Hold	8,033	–	–	0.15%	35
2023 Q1	$427K	Hold	8,033	–	–	0.11%	38
2022 Q4	$543K	Hold	8,033	–	–	0.2%	37
2022 Q3	$1M	Buy	+8,033	New	+$957K	0.36%	37

Other funds holding DNA

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

TB Alternative Assets's DNA Position: Q2 2024 in Review

TB Alternative Assets sold out of Ginkgo Bioworks (DNA) in Q2 2024, closing a stake of 18,625 shares — an estimated $864K sold.

TB Alternative Assets first reported a position in DNA in Q3 2022 and held it in 7 quarters. The position peaked at $1.26M in Q4 2023. 313 funds tracked by Wall St. Rank hold DNA as of Q2 2024.

TB Alternative Assets reported no remaining Ginkgo Bioworks position as of Q2 2024 after selling out during the quarter.
TB Alternative Assets sold 18,625 Ginkgo Bioworks shares in Q2 2024, an estimated $864K.
TB Alternative Assets first reported a position in Ginkgo Bioworks in Q3 2022 and held it in 7 quarters.
TB Alternative Assets's Ginkgo Bioworks position peaked at $1.26M in Q4 2023.
313 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2024.

Based on TB Alternative Assets's 13F filing for Q2 2024, filed 18 Jul 2024.